Table 3.
Strategy | Reduction
in Depression Prevalence |
Reduction
in Pre-ART Leakage |
Reduction in LTFU |
Increase in Adherence to ART |
Reduction in First Line ART Failure |
Increase
in Virologic Suppression |
---|---|---|---|---|---|---|
ADT Provision | 15.981 (15.841, 16.111) | −0.510 (−0.756, 0.349) | 3.722 (3.352, 4.092) | 1.014 (1.014, 1.015) | 2.526 (2.276, 2.775) | 1.005 (1.004, 1.006) |
ADT: antidepressant therapy; ART: antiretroviral therapy; LTFU: loss to followup.